Peripheral/Endo

Society for Vascular Surgery Vascular Quality Initiative Launches Carotid Care Quality Champion Program

September 05, 2024 09:09 AM Eastern Daylight Time CHICAGO–(BUSINESS WIRE)–The Society for Vascular Surgery® Vascular Quality Initiative® (SVS VQI) clinical registry today announced the Carotid Care Quality Champion recognition program. The program honors healthcare organizations across the country dedicated to improving the safety and effectiveness of vascular care through participation in the VQI’s […]

AngioDynamics Announces CE Mark Approval in Europe for the Auryon System

September 03, 2024 08:30 AM Eastern Daylight Time LATHAM, N.Y.–(BUSINESS WIRE)–AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving patient quality of life, today announced European CE Mark approval of the […]

Jupiter Endovascular Receives FDA Approval for U.S. Pivotal Study of Vertex Pulmonary Embolectomy System Using Endoportal Control

August 29, 2024 08:00 AM Eastern Daylight Time MENLO PARK, Calif.–(BUSINESS WIRE)–Jupiter Endovascular, Inc., a medical technology startup developing a new class of endovascular procedures using Endoportal Control™ to bring the precision and control of direct surgical access to catheter-based interventions, announced today that the U.S. Food and Drug Administration (FDA) has […]

Inari Medical Announces PEERLESS Data to be Presented During the Late-Breaking Clinical Trial Sessions at TCT 2024

IRVINE, Calif., Aug. 29, 2024 (GLOBE NEWSWIRE) —  Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, announced today that data from the PEERLESS trial will be presented by Dr. Wissam Jaber, Professor of Medicine at Emory University School of Medicine, during the Late-Breaking Clinical Trial Sessions at the 2024 Transcatheter Cardiovascular Therapeutics (TCT) Annual Scientific Symposium in Washington, D.C. The presentation will take place on October 29th.

National Blood Clot Alliance Appoints Healthcare Veteran Erin VanDyke as Vice President, VTE Centers of Excellence

PHILADELPHIA, Aug. 22, 2024 /PRNewswire/ — The National Blood Clot Alliance www.stoptheclot.org, the nation’s leading patient advocacy organization dedicated to advancing the prevention, early diagnosis, and successful treatment of venous blood clots, has announced the appointment of…

AVS Partners with the Jacobs Institute to Expedite Clinical Trials for Coronary and Carotid Indications

August 20, 2024 07:58 AM Eastern Daylight Time BOSTON–(BUSINESS WIRE)–Amplitude Vascular Systems (AVS), a medical device company focused on safely and effectively treating severely calcified arterial disease with its Pulse Intravascular Lithotripsy platform, today announced it has entered into a strategic agreement with the Jacobs Institute, a nonprofit medical device […]